Liberate Bio
Seed
AI for genetic medicine
Liberate Bio develops non-viral delivery technologies for nucleic acid cargoes, aiming to address genetic disorders.
Location
Boston, Massachusetts, United States
Stage
Seed
Website
LinkedIn
Founders
M
LinkedIn
News & Funding
Similar Startups
Centivax
Broad-spectrum vaccine
Obsidian Therapeutics
Series C
Cell and gene therapies
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
Sonoma BioTherapeutics
T cell therapies for autoimmune and inflammatory diseases
Human Longevity
Series B
Early detection for longer life
Janux Therapeutics
Immunotherapy to fight tumors